Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2017: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2016: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Outline of Final Research Achievements |
We tried to establish the mouse model of Tumor associated macrophage (TAM). We injected human tumor cell line into humanized mouse, but human macrophage was not penetrated to human tumor tissue. Therefore we focused on fibroblast which is other component of tumor microenvironment. Production of IL-6 and MCP-1 which are important for tumor cell proliferation and macrophage migration were upregulated when fibroblast was cultured by supernatant of tumor cell line. And these cytokine production by fibroblast were suppressed by treatment of steroid, p38 inhibitor and HSP90 inhibitor. Tumor cell proliferation in vivo was promoted by co-injection of fibroblast and tumor cells. But this phenomenon was not inhibited by p38 inhibitor treatment.
|